Process Development of Drugs Repurposed for COVID-19 | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Process Development of Drugs Repurposed for COVID-19

Implementing Organization

CSIR- National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram, Kerala

About

Process developed for Nitazoxanide, EIDD 1931 & EIDD 2801. Non-infringing routes developed for the APIs. Nitazoxanide is currently under clinical trials in Mexico. EIDD 2801 is currently under clinical trials in USA & UK.

Related Research

Quick Information

Focus Area

Development of Repurposed Drugs for COVID-19

Status

1

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

N/A

Startup (If Any)

00

No. of Patents

Filed :00

Grant :00